OpenPV Signal Explorer
FAERS disproportionality dashboard
← All drugs
Drug

Magnesium Chloride

130 flagged reaction(s) · 3,503 total co-reports · max PRR 56.2
Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
Reaction Co-reports (a) PRR ROR Signal
1 Hypercholesterolaemia 44 56.2 57.6 signal
2 Helicobacter Infection 39 46.7 47.8 signal
3 Pemphigus 46 45.2 46.4 signal
4 Folliculitis 38 44.9 45.9 signal
5 Joint Range Of Motion Decreased 47 42.9 44.1 signal
6 Back Injury 36 40.6 41.4 signal
7 Hand Deformity 43 40.1 41.1 signal
8 Bursitis 38 38.4 39.3 signal
9 Synovitis 56 37.9 39.1 signal
10 Pericarditis 49 35.9 36.9 signal
11 Glossodynia 60 32.7 33.9 signal
12 Taste Disorder 53 32.2 33.2 signal
13 Irritable Bowel Syndrome 54 30.8 31.8 signal
14 Red Blood Cell Sedimentation Rate Increased 26 28.6 29.0 signal
15 Wound Infection 24 26.9 27.3 signal
16 Obesity 33 25.2 25.7 signal
17 Liver Injury 43 21.7 22.2 signal
18 Wound 47 20.6 21.1 signal
19 Impaired Healing 52 19.3 19.9 signal
20 Laryngitis 16 17.9 18.1 signal
21 Night Sweats 46 17.4 17.8 signal
22 Contraindicated Product Administered 42 17.0 17.4 signal
23 Type 2 Diabetes Mellitus 46 16.6 17.0 signal
24 Psoriatic Arthropathy 54 16.4 16.8 signal
25 C-reactive Protein Increased 47 15.7 16.2 signal
26 Autoimmune Disorder 12 15.3 15.4 signal
27 Systemic Lupus Erythematosus 44 15.1 15.5 signal
28 Fibromyalgia 29 14.5 14.8 signal
29 Eructation 22 14.1 14.3 signal
30 Hypomagnesaemia 16 14.0 14.2 signal
31 Frequent Bowel Movements 30 13.6 13.8 signal
32 Osteoarthritis 47 13.5 13.8 signal
33 Infusion Related Reaction 72 13.3 13.8 signal
34 Epilepsy 32 12.8 13.0 signal
35 Liver Function Test Increased 22 12.6 12.7 signal
36 Musculoskeletal Pain 53 12.2 12.6 signal
37 Lung Disorder 49 12.2 12.5 signal
38 Iron Deficiency Anaemia 9 11.9 12.0 signal
39 Mucosal Inflammation 25 11.7 11.8 signal
40 Sciatica 15 11.5 11.6 signal
41 Maternal Exposure During Pregnancy 81 11.2 11.7 signal
42 Hepatic Cirrhosis 17 11.1 11.2 signal
43 Foot Deformity 10 11.0 11.0 signal
44 Ileus 11 10.9 10.9 signal
45 Lower Respiratory Tract Infection 40 10.7 11.0 signal
46 Inflammation 45 10.7 10.9 signal
47 Blister 48 10.4 10.7 signal
48 Cardiogenic Shock 12 10.2 10.3 signal
49 Therapeutic Product Effect Decreased 37 10.1 10.3 signal
50 Stomatitis 50 10.0 10.3 signal
51 Ear Pain 16 10.0 10.1 signal
52 Gait Inability 27 9.9 10.1 signal
53 Neck Pain 45 9.8 10.0 signal
54 Electrolyte Imbalance 9 9.5 9.6 signal
55 Hepatic Enzyme Increased 53 9.5 9.8 signal
56 Device Related Infection 12 9.5 9.5 signal
57 Osteoporosis 32 9.5 9.6 signal
58 Arthropathy 42 9.2 9.4 signal
59 Pulmonary Fibrosis 14 8.9 9.0 signal
60 Prescribed Overdose 14 8.8 8.9 signal
61 Blood Calcium Decreased 8 8.6 8.7 signal
62 Blood Cholesterol Increased 33 8.6 8.8 signal
63 Vaginal Discharge 7 8.5 8.5 signal
64 Full Blood Count Decreased 14 8.4 8.5 signal
65 Joint Stiffness 18 8.3 8.4 signal
66 Sleep Disorder Due To A General Medical Condition 11 8.3 8.3 signal
67 Dyspepsia 63 7.8 8.1 signal
68 Gastrooesophageal Reflux Disease 51 7.7 7.9 signal
69 Paraesthesia Oral 9 7.6 7.7 signal
70 Gout 11 7.5 7.5 signal
71 Sleep Disorder 42 7.3 7.5 signal
72 Swelling 55 7.2 7.4 signal
73 Macular Degeneration 7 7.1 7.2 signal
74 Migraine 55 7.1 7.3 signal
75 Small Intestinal Obstruction 7 6.9 7.0 signal
76 Colitis 21 6.8 6.9 signal
77 Oesophagitis 6 6.7 6.7 signal
78 Febrile Neutropenia 36 6.6 6.7 signal
79 Ill-defined Disorder 33 6.6 6.7 signal
80 Intentional Product Use Issue 47 6.5 6.7 signal
81 Respiratory Disorder 16 6.5 6.5 signal
82 Wheezing 31 6.4 6.5 signal
83 Memory Impairment 72 6.4 6.6 signal
84 Hyperkalaemia 18 6.3 6.3 signal
85 Therapeutic Product Effect Incomplete 36 6.2 6.3 signal
86 Rheumatoid Arthritis 56 6.0 6.2 signal
87 Pregnancy 10 6.0 6.0 signal
88 Joint Swelling 59 6.0 6.1 signal
89 Ear Infection 13 6.0 6.0 signal
90 Tooth Abscess 5 6.0 6.0 signal
91 Rectal Haemorrhage 21 5.9 6.0 signal
92 Drug-induced Liver Injury 15 5.9 6.0 signal
93 Exposure During Pregnancy 30 5.9 6.0 signal
94 Transfusion 5 5.8 5.8 signal
95 Mobility Decreased 34 5.8 5.9 signal
96 Rotator Cuff Syndrome 6 5.7 5.7 signal
97 Muscle Spasms 85 5.6 5.9 signal
98 Tooth Infection 6 5.5 5.5 signal
99 Treatment Failure 37 5.5 5.6 signal
100 Laboratory Test Abnormal 13 5.4 5.4 signal
101 Subdural Haematoma 6 5.1 5.1 signal
102 Hospice Care 4 4.9 4.9 signal
103 Insurance Issue 6 4.9 4.9 signal
104 Prescribed Underdose 8 4.9 4.9 signal
105 Respiratory Tract Congestion 6 4.6 4.6 signal
106 Adverse Reaction 5 4.6 4.6 signal
107 Hunger 5 4.5 4.5 signal
108 Ageusia 9 4.4 4.4 signal
109 Plasma Cell Myeloma 14 4.4 4.4 signal
110 Disability 7 4.3 4.3 signal
111 Post Procedural Haemorrhage 4 4.2 4.2 signal
112 Fluid Overload 5 4.1 4.1 signal
113 Laceration 3 3.8 3.8 no signal
114 Colitis Ulcerative 14 3.8 3.8 signal
115 Premature Delivery 5 3.8 3.8 signal
116 Coeliac Disease 3 3.7 3.7 no signal
117 Underdose 22 3.7 3.7 signal
118 Euphoric Mood 3 3.5 3.5 no signal
119 Procedural Pain 8 3.5 3.5 signal
120 Lactic Acidosis 9 3.4 3.4 signal
121 Myelodysplastic Syndrome 4 3.4 3.4 signal
122 Product Quality Issue 32 2.9 2.9 signal
123 Intraocular Pressure Increased 3 2.8 2.8 no signal
124 Hair Texture Abnormal 3 2.7 2.7 no signal
125 Injection Site Reaction 15 2.7 2.7 signal
126 Palmar-plantar Erythrodysaesthesia Syndrome 5 2.6 2.6 no signal
127 Foetal Exposure During Pregnancy 13 1.9 2.0 no signal
128 Exposure Via Skin Contact 3 1.6 1.6 no signal
129 Gastric Cancer 3 1.4 1.4 no signal
130 Pharmaceutical Product Complaint 3 1.4 1.4 no signal